会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Transdermal monolith systems
    • 超导单相系统
    • US5079008A
    • 1992-01-07
    • US547538
    • 1990-06-29
    • Joel SinnreichPeter Fankhauser
    • Joel SinnreichPeter Fankhauser
    • A61K9/70
    • A61K9/7053Y10S514/946Y10S514/947
    • The invention relates to a monolith transdermal therapeutic system for the delivery of permeable drugs, especially formoterol, in the form of a matrix system comprising three layers: a) a backing layer which is impermeable to the components of the adhesive layer b),b) an adhesive layer capable of releasing the drug and consisting of a permeable polymeric material which is compatible with the skin and contains at least one drug which is capable of permeation across the skin, a combination of eucalyptol having a purity of at least 70% with an additional flux enhancer and further optional pharmaceutical excipients, andc) a protective release liner which can be peeled from the adhesive contact layer b).
    • 本发明涉及一种整体式透皮治疗系统,用于以包含三层的基质系统的形式递送可渗透药物,特别是福莫特罗:a)对粘合剂层b)的组分不可渗透的背衬层,b) 能够释放药物并且由可渗透的聚合材料组成的粘合剂层,其与皮肤相容并且含有至少一种能够穿过皮肤渗透的药物,具有至少70%纯度的桉树脑和 额外的通量增强剂和另外的任选的药物赋形剂,和c)可以从粘合剂接触层b)剥离的保护性剥离衬垫。
    • 3. 发明授权
    • Covered retard forms
    • 覆盖延迟形式
    • US4996058A
    • 1991-02-26
    • US242833
    • 1988-09-12
    • Joel Sinnreich
    • Joel Sinnreich
    • A61K9/00A61K9/22A61K9/52A61K9/58A61K31/195A61K47/32A61P21/02
    • A61K9/009A61K9/0065
    • The invention relates to a covered, solid retard form which in the case of oral administration remains in the stomach during periodic emptying and ensures continuous release. This dosage form contains the following components:(a) at least one component that expands on contact with body fluid and that contains a physiologically active substance or a combination of such substances,(b) at least one permeable hydrophilic membrane which surrounds component (a) and which is expansible at the site of use, and optionally(c) a covering which surrounds components (a) and membrance (b) and which disintegrates without delay under the action of a body fluid at the site of use.
    • 本发明涉及覆盖的固体滞后形式,其在口服给药的情况下在定期排空期间保持在胃中并确保持续释放。 该剂型包含以下组分:(a)至少一种在与体液接触时膨胀并且含有生理活性物质或这些物质的组合的组分,(b)至少一种可渗透亲水膜,其包围组分(a ),并且其在使用部位是可膨胀的,以及任选地(c)围绕组分(a)和膜(b)的覆盖物,并且其在使用地点的体液作用下不会延迟地分解。
    • 7. 发明授权
    • Apparatus for simulating the effect of the living organism on the change
in shape, the disintegration and dissolution behaviour and the
active-ingredient release of a pharmaceutical dosage form
    • 用于模拟生物体对形状变化,药物剂型的分解和溶解行为和活性成分释放的影响的装置
    • US5827984A
    • 1998-10-27
    • US592419
    • 1996-02-06
    • Joel SinnreichChristian Bosshard
    • Joel SinnreichChristian Bosshard
    • A61K9/00G01N13/00G01N33/15
    • B01F1/0011B01F11/0082B01F11/0088G01N13/00G01N33/15G01N2013/006
    • An apparatus for simulating the effect of a living organism on the change in shape, the disintegration and dissolution behaviour and the active-ingredient release of a pharmaceutical dosage form, including a beaker-shaped container for accommodating a test medium and the pharmaceutical dosage form and an agitating device for agitating the test medium, which agitating device can be moved periodically in a reciprocating movement into and back out of the container, wherein the agitating device includes a piston-shaped head portion arranged on a piston rod, which head portion is provided with through-openings for the test medium and the distance of the piston-shaped head portion from the container floor can be altered periodically in accordance with the periodic reciprocating movement of the agitating device, wherein, the piston rod is suspended from a gallows-shaped boom or the piston rod passes through a bore in the gallows-shaped boom in such a manner that downward movement of the piston-shaped head portion arranged on the piston rod is caused by gravity alone and wherein there is arranged in the container an intermediate base supported on the container floor, the base being provided with through-openings for the test medium and serving as a support for the dosage form, wherein the distance between the intermediate base and the container floor is adjustable by a device for adjusting the distance between the base and the floor.
    • PCT No.PCT / EP94 / 02485第 371日期1996年2月6日 102(e)日期1996年2月6日PCT提交1994年7月28日PCT公布。 公开号WO95 / 15329 日期1995年6月8日一种用于模拟生物体对形状变化,药物剂型的崩解和溶解行为和活性成分释放的影响的装置,包括用于容纳测试介质的烧杯状容器和 所述药剂剂型和用于搅拌所述测试介质的搅拌装置,所述搅拌装置可以以往复运动方式周期性地移动进入和离开所述容器,其中所述搅拌装置包括布置在活塞杆上的活塞形头部, 该头部设置有用于测试介质的通孔,并且可以根据搅拌装置的周期性往复运动周期性地改变活塞头部与容器底板的距离,其中,活塞杆悬挂 从绞架形吊杆或活塞杆以向下移动的方式穿过绞架形吊杆中的孔 布置在活塞杆上的活塞头部的引导由重力单独引起,并且其中在容器中布置有支撑在容器底板上的中间基座,底座设置有用于测试介质的通孔,并用作 用于剂型的支撑件,其中中间基座和容器地板之间的距离可通过用于调节基座和地板之间的距离的装置来调节。
    • 8. 发明授权
    • Multilayer plaster
    • 多层石膏
    • US5032403A
    • 1991-07-16
    • US387322
    • 1989-07-28
    • Joel Sinnreich
    • Joel Sinnreich
    • A61K9/70A61K47/22
    • A61K9/7053A61K47/22Y10S514/946Y10S514/947
    • The invention relates to a transdermal therapeutic system in the form of a multilayer plaster for the administration of active substances which are able to permeate, in the form of a matrix system containing at least three layers:(a) a covering layer which is impermeable for the constituents of the reservoir b);(b) a reservoir layer which is able to deliver active substance and which consists of optionally crosslinked block copolymer based on styrene, alkadienes and optionally alkenes mixed with adhesive polymers and is optionally provided with an additional adhesive membrane layer and contains at least one active substance capable of skin permeation, at least one agent promoting the skin permeability of active substances and optionally further pharmaceutical auxiliaries, and(c) a protective film which can be pulled off the reservoir layer.
    • 本发明涉及一种多层石膏形式的透皮治疗系统,用于施用活性物质,活性物质能够以包含至少三层的基质体系的形式渗透:(a)不渗透的覆盖层, 水库的组成部分b); (b)储存层,其能够递送活性物质,并且由任选交联的基于苯乙烯,链烯二烯和任选的烯烃与粘合剂聚合物混合的嵌段共聚物组成,并且任选地具有另外的粘合膜层并且含有至少一种活性物质 能够皮肤渗透,促进活性物质的皮肤渗透性和任选的其它药物助剂的至少一种试剂,和(c)可以从储存层中拉出的保护膜。